AAAAAA
Results:
1-7
|
Results: 7
Authors:
Hebert, LA
Wilmer, WA
Falkenhain, ME
Ladson-Wofford, SE
Nahman, NS
Rovin, BH
Citation: La. Hebert et al., Renoprotection: One or many therapies?, KIDNEY INT, 59(4), 2001, pp. 1211-1226
Authors:
Saxena, R
Frankel, WL
Sedmak, DD
Falkenhain, ME
Cosio, FG
Citation: R. Saxena et al., Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: Successful treatment with plasmapheresis, AM J KIDNEY, 35(4), 2000, pp. 749-752
Authors:
Dooley, MA
Cosio, FG
Nachman, PH
Falkenhain, ME
Hogan, SL
Falk, RJ
Hebert, LA
Citation: Ma. Dooley et al., Mycophenolate mofetil therapy in lupus nephritis: Clinical observations, J AM S NEPH, 10(4), 1999, pp. 833-839
Authors:
Cosio, FG
Falkenhain, ME
Pesavento, TE
Yim, S
Alamir, A
Henry, ML
Ferguson, RM
Citation: Fg. Cosio et al., Patient survival after renal transplantation: II. The impact of smoking, CLIN TRANSP, 13(4), 1999, pp. 336-341
Authors:
Hebert, LA
Falkenhain, ME
Nahman, NS
Cosio, FG
O'Dorisio, TM
Citation: La. Hebert et al., Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy, AM J NEPHR, 19(1), 1999, pp. 1-6
Authors:
Pesavento, TE
Henry, ML
Falkenhain, ME
Cosio, FG
Bumgardner, GL
Elkhammas, EA
Pelletier, RP
Ferguson, RM
Citation: Te. Pesavento et al., Obese living kidney donors: Short-term results and possible implications, TRANSPLANT, 68(10), 1999, pp. 1491-1496
Authors:
Cosio, FG
Pelletier, RP
Sedmak, DD
Falkenhain, ME
Henry, ML
Elkhammas, EA
Davies, EA
Bumgardner, GL
Ferguson, RA
Citation: Fg. Cosio et al., Pathologic classification of chronic allograft nephropathy: pathogenic andprognostic implications, TRANSPLANT, 67(5), 1999, pp. 690-696
Risultati:
1-7
|